[go: up one dir, main page]

CA2437215A1 - Composes de dihydropyrazolopyridine et leur utilisation pharmaceutique - Google Patents

Composes de dihydropyrazolopyridine et leur utilisation pharmaceutique Download PDF

Info

Publication number
CA2437215A1
CA2437215A1 CA002437215A CA2437215A CA2437215A1 CA 2437215 A1 CA2437215 A1 CA 2437215A1 CA 002437215 A CA002437215 A CA 002437215A CA 2437215 A CA2437215 A CA 2437215A CA 2437215 A1 CA2437215 A1 CA 2437215A1
Authority
CA
Canada
Prior art keywords
dihydro
pyridine
pyrazolo
ethyl
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002437215A
Other languages
English (en)
Inventor
Toshiyuki Kohara
Kenji Fukunaga
Masatake Fujimura
Tokushi Hanano
Hirotaka Okabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2437215A1 publication Critical patent/CA2437215A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002437215A 2001-02-02 2002-02-01 Composes de dihydropyrazolopyridine et leur utilisation pharmaceutique Abandoned CA2437215A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2001026379 2001-02-02
JP2001-26379 2001-02-02
JP2001081238 2001-03-21
JP2001-81238 2001-03-21
JP2001-304707 2001-09-28
JP2001304707 2001-09-28
PCT/JP2002/000829 WO2002062795A2 (fr) 2001-02-02 2002-02-01 Composes de dihydropyrazolopyridine et leur utilisation pharmaceutique

Publications (1)

Publication Number Publication Date
CA2437215A1 true CA2437215A1 (fr) 2002-08-15

Family

ID=27345889

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002437215A Abandoned CA2437215A1 (fr) 2001-02-02 2002-02-01 Composes de dihydropyrazolopyridine et leur utilisation pharmaceutique

Country Status (6)

Country Link
EP (1) EP1355909A2 (fr)
JP (1) JP2005501800A (fr)
KR (1) KR20030076650A (fr)
CN (1) CN1630656A (fr)
CA (1) CA2437215A1 (fr)
WO (1) WO2002062795A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050069977A (ko) * 2002-08-07 2005-07-05 미쯔비시 웰 파마 가부시키가이샤 디히드로피라졸로피리딘 화합물
WO2004037814A1 (fr) * 2002-10-25 2004-05-06 Vertex Pharmaceuticals Incorporated Compositions indazolinones utiles en tant qu'inhibiteurs des kinases
PE20050521A1 (es) 2003-02-27 2005-09-11 Uriach Y Compania S A J Derivados de pirazolopiridina
ES2214150B1 (es) * 2003-02-27 2005-12-01 J. URIACH & CIA S.A. "nuevos derivados de pirazolopiridinas".
ES2335284T3 (es) * 2003-09-03 2010-03-24 Glaxo Group Limited Nuevo procedimiento para preparar derivados de pleuromutilina.
CA2562244A1 (fr) 2004-04-07 2005-10-27 Takeda Pharmaceutical Company Limited Composes cycliques
RS51351B (en) 2005-07-20 2011-02-28 Aventis Pharma S.A. 1,4-DIHYDROPYRIDINE-CONDENSED HTEROCYCLES, PROCEDURES FOR THEIR PRODUCTION, USE AND THE COMPOSITIONS CONTAINING THEM
CN102083429B (zh) 2008-04-24 2014-05-28 新联基因公司 Ido抑制剂
FR2945535B1 (fr) 2009-05-18 2011-06-10 Sanofi Aventis Compose anticancereux et composition pharmaceutique le contenant
US9096594B2 (en) 2012-10-12 2015-08-04 The Broad Institute, Inc. Kinase inhibitors and methods of use thereof
EA201992359A1 (ru) 2017-04-05 2020-03-12 Дзе Брод Инститьют Инк. Трициклические соединения в качестве ингибиторов киназы гликогенсинтазы-3 (gsk3) и их применение
US20220133740A1 (en) 2019-02-08 2022-05-05 Frequency Therapeutics, Inc. Valproic acid compounds and wnt agonists for treating ear disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法
JPS60197685A (ja) * 1984-03-19 1985-10-07 Shionogi & Co Ltd 4,7―ジヒドロピラゾロ[3,4―b]ピリジン誘導体とその製造法
GR79111B (fr) * 1982-12-20 1984-10-02 Lepetit Spa
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd 4,7−ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法
US4822799A (en) * 1988-01-27 1989-04-18 Sandoz Pharm. Corp. Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals
EP0355234A1 (fr) * 1988-08-25 1990-02-28 Merrell Dow Pharmaceuticals Inc. Dérivés de la pyrazolo-pyridine avec activité antiethérosclérotique et hypecholesthérolémique
EP0557290A1 (fr) * 1990-08-23 1993-09-01 The Children's Medical Center Corporation Traitement des demences, des myelopathies, des neuropathies peripheriques et des pertes de vision liees au sida
AU4956699A (en) * 1998-06-19 2000-01-05 Chiron Corporation Inhibitors of glycogen synthase kinase 3
CA2402179A1 (fr) * 2000-03-03 2001-09-13 Abbott Laboratories Agents ouvrant les canaux potassium a base de dihydropyrazolone tricyclique et de dihydroisoxazolone tricyclique
WO2001081345A1 (fr) * 2000-04-20 2001-11-01 Mitsubishi Pharma Corporation Composes d'amides aromatiques

Also Published As

Publication number Publication date
CN1630656A (zh) 2005-06-22
WO2002062795A3 (fr) 2003-05-30
WO2002062795A2 (fr) 2002-08-15
WO2002062795A9 (fr) 2002-10-10
EP1355909A2 (fr) 2003-10-29
JP2005501800A (ja) 2005-01-20
KR20030076650A (ko) 2003-09-26

Similar Documents

Publication Publication Date Title
DE60129210T2 (de) Zyklische amid-derivate
JP2793195B2 (ja) ベンゾチアゾール誘導体
EP0804437B1 (fr) DERIVES DE PYRROLE a]-ANNELES ET LEUR UTILISATION DANS LE DOMAINE PHARMACEUTIQUE
JP2008543726A (ja) 炎症性疾患の処置のためのpgd2受容体アンタゴニスト
WO2001081345A1 (fr) Composes d'amides aromatiques
JPH061788A (ja) 新規なアザインドール、その製造方法及びそれらを含む医薬品
AU7444898A (en) A new process for the preparation of a pharmacologically active substance
FR2959510A1 (fr) Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques
RU2154635C2 (ru) Производные 4-арил-6-амино-никотиновой кислоты и их соли
CA2966250C (fr) Derives benzo a cycle a six chainons en tant qu'inhibiteur de la dpp-4 et son utilisation
TW401299B (en) Use of 5-substituted pyridine-and hexahydroquinoline-3-carboxylic acid derivatives for the treatment of disorders of the central nervous system, novel active compounds, a process for their preparation and their use
CA1294967C (fr) Derives du 1h, 3h-pyrrolo [1,2-c] thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2437215A1 (fr) Composes de dihydropyrazolopyridine et leur utilisation pharmaceutique
US6977262B2 (en) Dihydropyrazolopyridine compounds and pharmaceutical use thereof
WO2016148114A1 (fr) Composé capable d'inhiber une mort de cellule neuronale induite par stress oxydatif
CZ657890A3 (cs) Chromanový derivát, způsob jeho výroby a farmaceutický prostředek s jeho obsahem
AU2018352828A1 (en) Antagonists of the muscarinic acetylcholine receptor M4
WO2014020101A1 (fr) Derives de griseofulvine
IL144229A (en) New history of N) –2– cyanoimino) thiazolidine – 4 – on
WO1986001510A1 (fr) Agents anti-inflammatoires a l'oxindole tricyclique
JP2959598B2 (ja) 光学活性なチエノトリアゾロジアゼピン化合物
NO317296B1 (no) Hypnotisk <beta>- karbolinderivater, fremgangsmater til deres fremstilling og deres anvendelse som legemiddelprodukt
WO2001014384A1 (fr) Derives dihydrobenzofuran tricycliques, leur procede de preparation et agents
JP5419894B2 (ja) Trpv3モジュレーターとしての縮合ピリミジン誘導体
JPH07252260A (ja) 新規チエノチアジン誘導体、その製造方法及びその使用方法

Legal Events

Date Code Title Description
FZDE Dead